Brad Williams has seen it all with supplement and pharma facilities. A 37-year veteran at the Food and Drug Administration, Williams has overseen the doling out of 483s and Warning Letters since the FDA issued its Good Manufacturing Practices (GMP) guidelines in 2008.
He’s seen it all, and he keeps seeing it, over and over again.
As part of the Dietary Supplements Health and Education Act (DSHEA) of 1994, the FDA was tasked with issuing GMP guidelines. I
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.